Skip to main content
STEX
NASDAQ Industrial Applications And Services

Streamex Appoints NYU Stern Finance Professor Anthony Marciano as Independent Director to Board and Audit Committee

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$3.04
Mkt Cap
$253.91M
52W Low
$0.4
52W High
$14.11
52W Position info
660% above low
Off High info
78% below high
Rel. Volume info
2.0× avg
Market data snapshot near publication time

STEX has more than doubled off its 52-week low of $0.4 on elevated volume (2.0× avg).

Summary

Streamex Corp. appointed Anthony Marciano, a distinguished finance professor and former investment banker, as an independent director and member of the Audit Committee, enhancing the board's financial expertise and governance.


Key Events · Executive and Board Changes · STEX

  • New Independent Director Appointed

    Anthony Marciano was appointed as an independent director to the Board of Directors, effective February 3, 2026.

  • Strong Financial and Academic Background

    Mr. Marciano brings over 40 years of experience in finance and academics, including roles as a Clinical Professor of Finance at NYU Stern, and prior senior positions at Goldman Sachs, Morgan Stanley, and Drexel Burnham Lambert.

  • Joins Audit Committee

    In addition to his board role, Mr. Marciano was appointed as a member of the company's Audit Committee, leveraging his deep financial expertise.

  • Compensation Details

    Mr. Marciano will receive an annual cash retainer of $40,000, plus an additional $25,000 for each committee served, along with eligible annual equity compensation.


Analysis · STEX · Industrial Applications And Services

Streamex Corp. has appointed Anthony Marciano, a highly experienced finance professional and academic, as an independent director to its Board and Audit Committee. Mr. Marciano's extensive background, including 40 years in finance, senior roles at Goldman Sachs and Morgan Stanley, and his current position as a Clinical Professor of Finance at NYU Stern, brings significant expertise in corporate finance, M&A, and financial markets. This appointment strengthens the company's governance and strategic capabilities, particularly given recent capital markets activity, including a significant insider purchase and the termination of a large equity purchase agreement. His independence and deep financial acumen are a positive signal for investors.

At the time of this filing, STEX was trading at $3.04 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $253.9M. The 52-week trading range was $0.40 to $14.11. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

STEX - Latest Insights

STEX
Jul 13, 2026, 5:19 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.8445
Real-time Price: $0.7378 info
Change: -$0.1067 (-13%) info
Market Cap: $76.934M info
STEX
Jul 07, 2026, 7:51 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $1.12
Real-time Price: $0.7378 info
Change: -$0.3822 (-34%) info
Market Cap: $76.934M info
STEX
May 28, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.52
Real-time Price: $0.7378 info
Change: -$0.7822 (-51%) info
Market Cap: $76.934M info
STEX
May 27, 2026, 6:05 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.40
Real-time Price: $0.7378 info
Change: -$0.6643 (-47%) info
Market Cap: $76.934M info
STEX
May 21, 2026, 4:47 PM EDT
Filing Type: 4
Importance Score:
7
Price at Filing: $1.20
Real-time Price: $0.7378 info
Change: -$0.4622 (-39%) info
Market Cap: $76.934M info